Anti-IL23 biologic therapies in the treatment of psoriasis: real-world experience versus clinical trials data
Angelo Ruggiero, Matteo Megna, Gabriella Fabbrocini, Sonia Sofìa Ocampo‐Garza
Topics & Concepts
MedicinePsoriasisInterleukin 23Clinical trialUstekinumabBiologic AgentsInterleukin 17Intensive care medicineImmunologyInternal medicineDiseaseImmune systemAdalimumabPsoriasis: Treatment and PathogenesisDermatology and Skin DiseasesAsthma and respiratory diseases